Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

Bullboard Posts
Comment by nlegallon Aug 09, 2008 8:23pm
195 Views
Post# 15371968

RE: MAGILLA GORILLA

RE: MAGILLA GORILLA

Maggie let me help you do some home work.
All paid for by PAHO UNAIDS, UNICEF and the WHO.

From Sedar April MD&A.


https://www.sedar.com/GetFile.do?lang=EN&docClass=7&issuerNo=00013053&fileName=/csfsprod/data91/filings/01288190/00000001/k%3A%5CSedar%5Cfilings%5Clivework%5Cwkout%5C20903%5CMDA.pdf

Business Development

Building on our USAID approval in the previous quarter, MedMira continues to open new sales channels with procurement and aid agencies involved in global public health programs. This quarter MedMira became an approved supplier to the Pan American Health Organization (PAHO). PAHO, headquartered in Washington, DC, is an international public health agency working with Latin America and Caribbean countries on priority health issues such as HIV. It also serves as the regional office for the World Health Organization (WHO) in the Americas. MedMira’s first PAHO product order was from the Ministry of Health in Belize, which is using our rapid HIV tests in its HIV/AIDS prevention program.

"The Belize Ministry of Health is committed to delivering the best in healthcare services to our people and MedMira’s rapid HIV test enables us to significantly increase the availability and reliability of testing in our HIV/AIDS prevention programs," said Dr. Marvin Manzanero, Director of National TB, HIV/AIDS and other STIs Programme, Ministry of Health Belmopan, Belize.

Building global sales channels and relationships with organizations such as USAID and PAHO enables MedMira to participate in large scale tender opportunities and supply diagnostics to much needed programs run by aid agencies and organizations like UNAIDS, UNICEF and the WHO.

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse